The company is a state-owned biomedical high-tech enterprise that is dominated by molecular diagnostic technology and integrates independent R&D, production and sales of clinical test reagents, instruments and supporting consumables. As one of the first high-tech enterprises in vitro diagnosis in the country, the company was listed on the Shenzhen Stock Exchange in 2004. The company is a biomedical high-tech enterprise which is dominated by molecular diagnostic technology and integrates R&D, production and sales of clinical test reagents, instruments and supporting consumables. Main products: fluorescence quantitative PCR series products, sequencing series products, mass spectrometry series products, chemiluminescence series products, time-resolved series products, ELISA series products, POCT series products, biochemical series products, etc., instrument series products. Corporate honors: The first batch of national-level intellectual property advantage enterprises in 2013; 2008 to 2009 A tax certificate; 2010 Guangzhou's first outstanding independent innovation enterprise; 2010 Guangzhou Engineering Technology Research and Development Center; 2010 Guangdong Top Ten Innovative Enterprises Nomination Award; 2010 Guangdong Famous Trademark Certificate, etc.
No Data